Cypress Capital Management (Wyoming)’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-66
| Closed | -$117 | – | 169 |
|
|
2024
Q4 | $117 | Hold |
66
| – | – | ﹤0.01% | 145 |
|
|
2024
Q3 | $72 | Buy |
+66
| New | +$72 | ﹤0.01% | 161 |
|
|
2024
Q1 | – | Sell |
-66
| Closed | -$130 | – | 178 |
|
|
2023
Q4 | $130 | Hold |
66
| – | – | ﹤0.01% | 166 |
|
|
2023
Q3 | $53 | Hold |
66
| – | – | ﹤0.01% | 175 |
|
|
2023
Q2 | $71 | Hold |
66
| – | – | ﹤0.01% | 168 |
|
|
2023
Q1 | $66 | Hold |
66
| – | – | ﹤0.01% | 160 |
|
|
2022
Q4 | $55 | Hold |
66
| – | – | ﹤0.01% | 161 |
|
|
2022
Q3 | $0 | Sell |
66
-1
| -1% | – | ﹤0.01% | 164 |
|
|
2022
Q2 | $0 | Hold |
67
| – | – | ﹤0.01% | 175 |
|
|
2022
Q1 | $0 | Hold |
67
| – | – | ﹤0.01% | 220 |
|
|
2021
Q4 | $0 | Hold |
67
| – | – | ﹤0.01% | 287 |
|
|
2021
Q3 | $1K | Hold |
67
| – | – | ﹤0.01% | 232 |
|
|
2021
Q2 | $2K | Hold |
67
| – | – | ﹤0.01% | 279 |
|
|
2021
Q1 | $1K | Hold |
67
| – | – | ﹤0.01% | 272 |
|
|
2020
Q4 | $1K | Hold |
67
| – | – | ﹤0.01% | 216 |
|
|
2020
Q3 | $1K | Hold |
67
| – | – | ﹤0.01% | 197 |
|
|
2020
Q2 | $1K | Hold |
67
| – | – | ﹤0.01% | 186 |
|
|
2020
Q1 | $3K | Hold |
67
| – | – | ﹤0.01% | 163 |
|
|
2019
Q4 | $5K | Hold |
67
| – | – | ﹤0.01% | 159 |
|
|
2019
Q3 | $6K | Hold |
67
| – | – | 0.01% | 159 |
|
|
2019
Q2 | $7K | Hold |
67
| – | – | 0.01% | 202 |
|
|
2019
Q1 | $8K | Hold |
67
| – | – | 0.01% | 196 |
|
|
2018
Q4 | $5K | Hold |
67
| – | – | 0.01% | 252 |
|
|
2018
Q3 | $7K | Hold |
67
| – | – | 0.01% | 290 |
|
|
2018
Q2 | $11K | Buy |
+67
| New | +$11K | 0.01% | 257 |
|